BONITA SPRINGS, Fla., July 31, 2023 /PRNewswire/ — On or about June 1, 2023, Discovery at Home (DAH) became aware that a team member had fallen victim to a phishing email scheme which resulted in the inadvertent transmittal of personal health information via unencrypted e-mail to an unauthorized third-party sender. DAH has worked diligently to determine … Read more
Mit dem Ziel, die Akzeptanz von DCTs in Europa zu erhöhen und Sponsoren auf dem Weg in die Welt virtueller Studien zu unterstützen, , ist das Unternehmen auf dem besten Weg, im September 2023 eine europäische DCT-Lösung auf den Markt zu bringen. LIVERPOOL, Vereinigtes Königreich, 31. Juli 2023 /PRNewswire/ — Mit der Übernahme von emovis, … Read more
SAN DIEGO, July 30, 2023 /PRNewswire/ — Synergy Orthopedic Specialists, the largest independent physician-owned, physician-led medical practice in San Diego, continues its growth in San Diego and Riverside Counties by merging Thomas W. Harris, MD’s worker’s compensation medical practice. Additionally, the esteemed group proudly welcomes two new exceptional physicians, Pascual Dutton, MD, and Scot Youngblood, … Read more
Proceeds from the event will benefit the Herbalife Nutrition Foundation SAN ANTONIO, July 29, 2023 /PRNewswire/ — Herbalife, a premier health and wellness company and community, took to Market Street today to host its Fit Hour, a live workout for approximately 5,000 Herbalife distributors from across the United States to encourage people to get up … Read more
NEW YORK, July 28, 2023 /PRNewswire/ — The immunodiagnostics market size is set to grow by USD 22,669.75 million between 2022 and 2027 and register an accelerating CAGR of 12%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by the way of synthesis, and … Read more
HONG KONG, Germantown, Md. and SUZHOU, China, July 27, 2023 /PRNewswire/ — Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that Dr. Francois Lebel, M.D., an experienced biopharmaceutical industry executive, has been appointed as Senior Vice President for preclinical and clinical development of the … Read more
NEW YORK, July 27, 2023 /PRNewswire/ — The RNAi drug delivery market is expected to grow by USD 109.73 billion from 2022 to 2027, progressing at a CAGR of 20.83% as per the latest Technavio market research report. North America is going to have lucrative growth during the forecast period. About 46% of the market’s overall growth … Read more
Possibilité d’avoir un impact plus large car 70 % des leaders d’opinion clés n’interagissent qu’avec une seule entreprise biopharmaceutique BARCELONE, Espagne, 26 juillet 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a révélé aujourd’hui les résultats de l’impact de la médecine de terrain sur la pratique clinique dans le rapport Veeva Pulse Field Trends. L’analyse montre que l’éducation sur l’état de … Read more
Signal of PFS Improvement in SIENDO for Selinexor-Treated Patients was Observed Only in Subgroup Who are TP53 Wild-Type with a Median Progression-Free Survival of 27.4 Months Median PFS Not Reached for Selinexor-Treated Patients Who are TP53 Wild-Type MSS (pMMR) Updated Analysis Provides Further Rationale for XPORT-EC-042, the Ongoing Pivotal Phase 3 Study (NCT05611931) Evaluating Selinexor … Read more
DUBLIN, July 24, 2023 /PRNewswire/ — The “Testosterone Replacement Therapy Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers, and senior management with critical information needed to assess the Testosterone Replacement Therapy market. The market is projected to grow from $1.75 billion in 2022 to $1.85 billion in 2023, … Read more